Cardinal Health today announced that it has signed a renewed, three-year agreement with Prime Therapeutics, one of the nation's leading pharmacy benefit managers, to continue to serve as its primary pharmaceutical supply chain partner for its mail-service pharmacy, PrimeMail®.
Prime Therapeutics managed more than $10.2 billion in prescription drug spend in 2010, and currently serves nearly 17 million members through Blue Cross and Blue Shield Plans, employer and union groups and third-party administrators.
"We look forward to continuing to deliver the kind of flexible and innovative pharmaceutical distribution services that help Prime Therapeutics to efficiently and effectively serve its patients' medication needs," said Jon Giacomin, president of Cardinal Health's U.S. Pharmaceutical Distribution business. "This renewed agreement is an excellent example of our commitment to building mutually beneficial customer relationships that enable us to grow our pharmaceutical distribution business while also improving the overall costs of healthcare."
Cardinal Health will also continue to offer Prime Therapeutics additional supply chain optimization services to help improve its operational efficiency.
"Our strong and flexible partnership with Cardinal Health has enabled us to leverage their operational excellence and economic value to cost-effectively purchase medications, while we also continue to engage and maximize our own direct generic purchasing," said Peter Wickersham, Prime Therapeutics Senior Vice President of Cost of Care. "Cardinal Health consistently delivers the experience and value-added services that we need to help us to continue delivering quality, cost-efficient prescription drug benefits to our customers."
Natural killer cells lead the charge in cancer treatment innovation